Top Vaccines companies in United States by Return on Assets (ROA)

This ranking features the top 115 Vaccines companies in United States ranked by Return on Assets (ROA), averaging a Return on Assets (ROA) of -31.00%, for February 04, 2025.

United States

Vaccines

#	Name	Return on Assets (ROA)	Reported Date	Stock Price	Change	Country
1	SIGA Technologies, Inc. 1 SIGA	38.70%	Sept. 30, 2024	USD 5.78	-3.34%	United States
2	Protagonist Therapeutics, Inc. 2 PTGX	30.98%	Sept. 30, 2024	USD 37.20	-1.59%	United States
3	ADMA Biologics, Inc. 3 ADMA	18.83%	Sept. 30, 2024	USD 16.47	1.98%	United States
4	Zoetis Inc. 4 ZTS	17.01%	Sept. 30, 2024	USD 171.94	0.61%	United States
5	United Therapeutics Corporation 5 UTHR	16.15%	Sept. 30, 2024	USD 354.58	0.97%	United States
6	Regeneron Pharmaceuticals, Inc. 6 REGN	13.21%	Sept. 30, 2024	USD 666.85	-0.91%	United States
7	Merck & Co., Inc. 7 MRK	10.98%	Sept. 30, 2024	USD 99.79	0.98%	United States
8	Entrada Therapeutics, Inc. 8 TRDA	10.38%	Sept. 30, 2024	USD 13.33	-0.82%	United States
9	Abbott Laboratories 9 ABT	7.87%	Sept. 30, 2024	USD 128.45	0.41%	United States
10	Thermo Fisher Scientific Inc. 10 TMO	6.44%	Dec. 31, 2024	USD 593.75	-0.67%	United States
11	Biogen Inc. 11 BIIB	5.95%	Sept. 30, 2024	USD 142.34	-1.10%	United States
12	Charles River Laboratories International, Inc. 12 CRL	5.12%	Sept. 28, 2024	USD 161.62	-1.91%	United States
13	Laboratory Corporation of America Holdings 13 LH	2.54%	Sept. 30, 2024	USD 247.86	-0.78%	United States
14	DLH Holdings Corp. 14 DLHC	2.28%	Sept. 30, 2024	USD 7.39	-1.47%	United States
15	Dynavax Technologies Corporation 15 DVAX	2.02%	Sept. 30, 2024	USD 12.94	-0.84%	United States
16	Pfizer Inc. 16 PFE	1.93%	Sept. 29, 2024	USD 26.20	-1.21%	United States
17	Phibro Animal Health Corporation 17 PAHC	1.79%	Sept. 30, 2024	USD 21.69	-0.55%	United States
18	Gilead Sciences, Inc. 18 GILD	0.22%	Sept. 30, 2024	USD 98.38	1.21%	United States
19	Radius Recycling, Inc. 19 RDUS	-1.47%	Nov. 30, 2023	USD 11.89	0.59%	United States
20	Cytek Biosciences, Inc. 20 CTKB	-2.07%	Sept. 30, 2024	USD 5.39	4.66%	United States
21	Vanda Pharmaceuticals Inc. 21 VNDA	-2.52%	Sept. 30, 2024	USD 4.31	-2.27%	United States
22	Exact Sciences Corporation 22 EXAS	-3.26%	Sept. 30, 2024	USD 55.24	-1.44%	United States
23	Third Harmonic Bio, Inc. 23 THRD	-5.34%	March 31, 2024	USD 5.03	-4.37%	United States
24	Bristol-Myers Squibb Company 24 BMY	-7.59%	Sept. 30, 2024	USD 59.95	1.70%	United States
25	Alnylam Pharmaceuticals, Inc. 25 ALNY	-8.38%	Sept. 30, 2024	USD 274.55	1.19%	United States
26	iTeos Therapeutics, Inc. 26 ITOS	-8.61%	Sept. 30, 2023	USD 7.37	-2.25%	United States
27	Quanterix Corporation 27 QTRX	-9.72%	Sept. 30, 2024	USD 8.83	-3.92%	United States
28	OPKO Health, Inc. 28 OPK	-12.12%	June 30, 2024	USD 1.50	-1.32%	United States
29	Ionis Pharmaceuticals, Inc. 29 IONS	-12.45%	Sept. 30, 2024	USD 32.13	0.72%	United States
30	Emergent BioSolutions Inc. 30 EBS	-12.60%	Sept. 30, 2024	USD 10.49	-6.76%	United States
31	Moderna, Inc. 31 MRNA	-13.35%	Sept. 30, 2024	USD 36.55	-7.28%	United States
32	Cumberland Pharmaceuticals Inc. 32 CPIX	-13.65%	Sept. 30, 2024	USD 2.13	-5.75%	United States
33	BioLife Solutions, Inc. 33 BLFS	-15.18%	March 31, 2024	USD 26.62	-2.53%	United States
34	Amylyx Pharmaceuticals, Inc. 34 AMLX	-15.33%	March 31, 2024	USD 3.42	-6.30%	United States
35	Structure Therapeutics Inc. 35 GPCR	-15.71%	Sept. 30, 2024	USD 28.35	-5.41%	United States
36	Tourmaline Bio, Inc. 36 TRML	-15.72%	Sept. 30, 2024	USD 15.54	-3.24%	United States
37	Arcturus Therapeutics Holdings Inc. 37 ARCT	-16.25%	June 30, 2024	USD 15.80	-6.89%	United States
38	Applied BioCode Corporation 38 6598.TW	-16.53%	Dec. 31, 2023	USD 0.69	NA	United States
39	Novavax, Inc. 39 NVAX	-16.91%	Sept. 30, 2024	USD 8.43	-2.99%	United States
40	Janux Therapeutics, Inc. 40 JANX	-17.32%	Sept. 30, 2023	USD 42.07	-3.24%	United States
41	Alector, Inc. 41 ALEC	-18.29%	March 31, 2024	USD 1.64	-1.21%	United States
42	Cryoport, Inc. 42 CYRX	-18.35%	Sept. 30, 2024	USD 7.38	-2.12%	United States
43	Y-mAbs Therapeutics, Inc. 43 YMAB	-18.49%	Sept. 30, 2024	USD 5.80	-2.85%	United States
44	IDEAYA Biosciences, Inc. 44 IDYA	-18.63%	Sept. 30, 2024	USD 23.64	-2.92%	United States
45	Dianthus Therapeutics, Inc. 45 DNTH	-20.88%	Sept. 30, 2024	USD 22.07	-0.36%	United States
46	Apogee Therapeutics, Inc. 46 APGE	-20.94%	Sept. 30, 2024	USD 40.37	-2.39%	United States
47	Xencor, Inc. 47 XNCR	-21.74%	Sept. 30, 2024	USD 17.62	-3.61%	United States
48	Vaxcyte, Inc. 48 PCVX	-22.20%	Sept. 30, 2024	USD 84.81	-3.97%	United States
49	Kymera Therapeutics, Inc. 49 KYMR	-22.37%	June 30, 2024	USD 38.49	-2.78%	United States
50	Arcus Biosciences, Inc. 50 RCUS	-22.38%	Sept. 30, 2024	USD 13.20	2.33%	United States

1 2 3

Frequently Asked Questions

Which Vaccines company in United States has the highest Return on Assets (ROA) ?

The Vaccines company in United States with the highest Return on Assets (ROA) is SIGA Technologies, Inc. (NasdaqGM: SIGA) at 38.70%.
Which Vaccines company in United States has the lowest Return on Assets (ROA) ?

The Vaccines company in United States with the lowest Return on Assets (ROA) is Galectin Therapeutics Inc. (NasdaqCM: GALT) at -170.36%.

What are the top 10 Vaccines companies in United States by Return on Assets (ROA) ?

The top 10 Vaccines companies in United States by Return on Assets (ROA) are SIGA Technologies, Inc., Protagonist Therapeutics, Inc., ADMA Biologics, Inc., Zoetis Inc., United Therapeutics Corporation, Regeneron Pharmaceuticals, Inc., Merck & Co., Inc., Entrada Therapeutics, Inc., Abbott Laboratories and Thermo Fisher Scientific Inc..
What are the bottom 10 Vaccines companies in United States by Return on Assets (ROA) ?

The bottom 10 Vaccines companies in United States by Return on Assets (ROA) are Galectin Therapeutics Inc., Elicio Therapeutics, Inc., Gain Therapeutics, Inc., Cidara Therapeutics, Inc., Immunome, Inc., Phathom Pharmaceuticals, Inc., KalVista Pharmaceuticals, Inc., Invivyd, Inc., Rhythm Pharmaceuticals, Inc. and Cue Biopharma, Inc..

Frequently Asked Questions

Don’t Miss A Beat